What Are the Long-Term Skeletal Outcomes after Aromatase Inhibitor Discontinuation?
Post-aromatase inhibitor therapy, the skeleton begins a partial, site-specific recovery of bone density as natural estrogen signaling resumes.
HRTioJuly 25, 2025